Advanced Sterilization Products Device Company Intelligence Report
 
Report

Advanced Sterilization Products Device Company Intelligence ReportMedical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation.

From:
$395
 
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available. Headquartered in Irvine, California, USA, Johnson & Johnson's Advanced Sterilization Products (ASP) division manufactures and markets a full range of sterilisation and disinfection technologies.

ASP's sterilising systems are marketed under the Sterrad brand-name. Since its introduction in 1993, Sterrad technology has processed more than 34 million instrument loads in more than 7,000 systems worldwide. The company's latest-generation system, Sterrad NX, was launched in the US in May 2005.

In addition to its Sterrad systems, ASP markets an automated endoscope reprocessing system which is manufactured by Minntech.

This report is also available as an integral part of Espicom's Johnson & Johnson Company Intelligence Report, covering the whole of that company's Medical Devices & Diagnostic business segment.

Report Details:
Publisher:
Espicom
Type:
Market Briefing - September 2005
Number of pages:
12
First Publication Date:
27/9/2005
 
 
 
Copyright © Chiltern Magazine Services Ltd | Email: admin@cmsinfo.com | Tel: +(1) 508 861 0401